Aethlon Medical Stock Performance
| AEMD Stock | USD 0.37 0.02 5.71% |
The firm shows a Beta (market volatility) of 0.83, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aethlon Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aethlon Medical is expected to be smaller as well. At this point, Aethlon Medical has a negative expected return of -0.0034%. Please make sure to confirm Aethlon Medical's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Aethlon Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Over the last 90 days Aethlon Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Aethlon Medical is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:10 | Dividend Date 2019-10-15 | Last Split Date 2023-10-05 |
1 | Disposition of 3289 shares by Shah Chetan of Aethlon Medical at 0.466 subject to Rule 16b-3 | 09/30/2024 |
2 | Acquisition by Cipriani Guy F. of 100200 shares of Aethlon Medical at 1.41 subject to Rule 16b-3 | 10/04/2024 |
3 | Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit | 10/08/2024 |
4 | Aethlon Medical Coverage Initiated by Analysts at StockNews.com | 10/18/2024 |
5 | AEMD - AETHLON MEDICAL INC Latest Stock News Market Updates - StockTitan | 11/11/2024 |
6 | Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update | 11/13/2024 |
7 | Aethlon Medical Inc Q2 2025 Earnings Call Highlights Progress in Oncology Trials and ... | 11/14/2024 |
8 | Acquisition by Cipriani Guy F. of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 | 11/26/2024 |
| Begin Period Cash Flow | 14.6 M |
Aethlon |
Aethlon Medical Relative Risk vs. Return Landscape
If you would invest 39.00 in Aethlon Medical on September 19, 2024 and sell it today you would lose (2.00) from holding Aethlon Medical or give up 5.13% of portfolio value over 90 days. Aethlon Medical is currently does not generate positive expected returns and assumes 4.0794% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Aethlon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aethlon Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aethlon Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aethlon Medical, and traders can use it to determine the average amount a Aethlon Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -8.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AEMD |
Estimated Market Risk
| 4.08 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aethlon Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aethlon Medical by adding Aethlon Medical to a well-diversified portfolio.
Aethlon Medical Fundamentals Growth
Aethlon Stock prices reflect investors' perceptions of the future prospects and financial health of Aethlon Medical, and Aethlon Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aethlon Stock performance.
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.5 | ||||
| Current Valuation | (954.72 K) | ||||
| Shares Outstanding | 13.96 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 2.37 X | ||||
| Gross Profit | 574.25 K | ||||
| EBITDA | (11.85 M) | ||||
| Net Income | (12.21 M) | ||||
| Cash And Equivalents | 14.92 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 940.32 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 9.66 X | ||||
| Book Value Per Share | 2.19 X | ||||
| Cash Flow From Operations | (10.13 M) | ||||
| Earnings Per Share | (2.79) X | ||||
| Market Capitalization | 5.11 M | ||||
| Total Asset | 8.25 M | ||||
| Retained Earnings | (154.57 M) | ||||
| Working Capital | 4.4 M | ||||
| Current Asset | 817 K | ||||
| Current Liabilities | 1.08 M | ||||
About Aethlon Medical Performance
By analyzing Aethlon Medical's fundamental ratios, stakeholders can gain valuable insights into Aethlon Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aethlon Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aethlon Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.48) | (1.55) | |
| Return On Capital Employed | (1.97) | (1.87) | |
| Return On Assets | (1.48) | (1.55) | |
| Return On Equity | (2.12) | (2.01) |
Things to note about Aethlon Medical performance evaluation
Checking the ongoing alerts about Aethlon Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aethlon Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aethlon Medical generated a negative expected return over the last 90 days | |
| Aethlon Medical has some characteristics of a very speculative penny stock | |
| Aethlon Medical has high historical volatility and very poor performance | |
| Aethlon Medical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.21 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Aethlon Medical has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Cipriani Guy F. of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 |
- Analyzing Aethlon Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aethlon Medical's stock is overvalued or undervalued compared to its peers.
- Examining Aethlon Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aethlon Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aethlon Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aethlon Medical's stock. These opinions can provide insight into Aethlon Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |